Tumour cells demonstrated immunopositivity for pancytokeratin, vimentin, CD10
, CK19 and AMACR (Fig.
The tumor cells were immunohistochemically reactive for RCC antigen, CD10
, CK903, P504-S (AMACR), and PAX8.
Immunohistochemical studies were undertaken using antibodies CK7 (1:750 Dako), cytokeratin AE1/AE3 (1:1000 Dako), EMA (1:750 Dako), CD10
(1:300 Novocastra), vimentin (1:4000 Dako), S100 (1:4000 Dako), TTF-1 (1:250 Novocastra) and thyroglobulin (1:500 Dako).
In general, most cases of lymphoblastic lymphoma/ leukemia involving extramedullary sites are of immature T-cell lineage, express a variety of T-cell antigens as well as CD10
and TdT (bright, often uniform), and are negative for myeloperoxidase, lysozyme, and CD68.
Identification of a high-risk subset with coexpression of CD10
The primary tumor cells were diffusely positive for CD10
, vimentin (VIM) and CD68 (Figure 3).
ECE-1 and CD10
protein expression in invasive breast cancer.
CD3 and CD10
staining were performed and showed an admixture of T cells and B cells; no evidence of malignancy was found.
In some instances, having a CD10
conviction could add as much as an extra [pounds]402 to the cost, an increase of 63 per cent.
Pathological analysis revealed a malignant spindle cell tumor with negative immunohistochemical staining for CD117 and CD10
and mild reactivity for desmin and muscle specific actin, making low grade leiomyosarcoma the most likely diagnosis.
The majority of children will develop common ALL, which characteristically has CD10
expression on the surface of the leukaemia blasts.
Biyopsi materyalinin immunohistokimyasal incelemesinde CD-20 pozitifligi, CD3, CD5, CD10